Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

GE HealthCare Technologies Inc. (GEHC) vs Smith & Nephew SNATS, Inc. (SNN)

GE HealthCare Technologies Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. GE HealthCare Technologies Inc. is the larger, with a market value of $29.9B against $11.2B — 2.7× the size. GE HealthCare Technologies Inc. trades at the lower P/E: 15.3× against 32.8×. GE HealthCare Technologies Inc. grew revenue faster over the last twelve months: 6.51% against 4.81%. GE HealthCare Technologies Inc. has the higher net margin (9.33% vs 6.71%) and the higher return on invested capital (8.37% vs 0.00%). Both pay a dividend; Smith & Nephew SNATS, Inc. yields more (2.67% vs 0.13%). Across the 23 metrics below, Smith & Nephew SNATS, Inc. leads on 14 and GE HealthCare Technologies Inc. on 9.

Valuation

Metric GEHC SNN Medical Devices median
P/E 15.28 32.80 22.18
P/S 1.42 1.15 2.70
P/B 2.75 2.33 2.46
Price to free cash flow 19.12 5.97 22.53
EV/EBITDA 11.85 5.66 11.78
EV/Sales 1.86 1.39 2.38
Earnings yield 6.54% 3.05% (8.22%)
Free cash flow yield 5.23% 16.74% (7.80%)

Profitability

Metric GEHC SNN Medical Devices median
Gross margin 39.54% 70.52% 56.01%
Operating margin 12.86% 0.00% (15.03%)
Net margin 9.33% 6.71% (20.40%)
Free cash flow margin 7.42% 0.00% (7.24%)
Return on equity 19.15% 0.00% (15.32%)
Return on assets 5.45% 0.00% (19.72%)
Return on invested capital 8.37% 0.00% (10.33%)

Growth

Metric GEHC SNN Medical Devices median
Revenue growth (TTM) 6.51% 4.81% 8.80%
EPS growth (last fiscal year) 4.84% 52.34% —
Revenue growth, 5-year CAGR 3.74% 6.21% 15.23%
Net income growth, 5-year CAGR (31.53%) 6.89% 0.00%

Health

Metric GEHC SNN Medical Devices median
Debt to equity 1.05 0.62 0.07
Current ratio 1.26 2.14 2.50
Net debt to EBITDA 2.14 1.92 0.49

Dividend

Metric GEHC SNN Medical Devices median
Dividend yield 0.13% 2.67% 0.94%
Payout ratio — 1.50 0.00

Size

Metric GEHC SNN Medical Devices median
Market cap 29.86b 11.17b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack